Navigation Links
MediGain Announces Release of New Oncology Analytics Solution
Date:1/4/2012

DALLAS, Jan. 4, 2012 /PRNewswire-iReach/ -- MediGain, a national leader in revenue cycle management and financial analytics, today announced the release of OptimOncology, a financial analytics tool that correlates all drug and financial costing for office-based oncology practices.  This unique technology aggregates financial, clinical and drug utilization data and provides measurable results for oncology practices.

"Drug costs are one of the top concerns in all oncology practices.  Reimbursements from the government and private payers continue to decrease.  Our goal is to provide premium care for our patients with the best possible outcomes.  MediGain's solutions help us do just that," stated California oncologist James Berenson, MD. 

In an industry where costs are soaring and payer reimbursements are declining, the prosperity, and sometimes survival, of a practice can depend upon the availability of quality information.  For oncology practices, the OptimOncology solution means physicians have quick access to financial analysis and clinical decision support that has never before been available in an office-based setting. The OptimOncology technology allows them to make more timely and profitable business decisions. 

"We are very excited to have the first true analytics technology for office-based oncology practices," stated Greg Hackney, CEO of MediGain. "This will be a revolutionary milestone in the evolution of oncology practices.  Physicians will be able to quickly understand how the current and future costs and reimbursements will affect their financial performance."

OptimOncology is offered on a web-based analytics platform and supported by client service teams with deep healthcare expertise, allowing the physician to have instant access to the analysis and trends of his practice.

About MediGain:  MediGain is a national Revenue Cycle Management and Financial Analytics company devoted to improving billing, reimbursement collections, and outcomes for healthcare providers and the patients they serve. With over 300 employees, MediGain provides solutions for physician groups, provider networks, and hospitals enabling them to reach their maximum potential through improved operational, financial, and clinical outcomes. 

Media Contact: Corianne Standerfer MediGain, 972-675-7344, corianne.standerfer@medigain.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE MediGain
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Aethlon Medical Announces Biotech Showcase™ 2012 Presentation
2. OncoGenex Announces Publication of Phase I/II Custirsen (OGX-011/TV-1011) Data in Journal of Thoracic Oncology
3. Echo Therapeutics Announces $3.6 Million Warrant Exercises
4. Shield HealthCare Announces Caregiver Story Contest Winners
5. PDL BioPharma Announces Expiration and Preliminary Results of its Exchange Offer
6. Radient Pharmaceuticals Announces Reverse Stock Split
7. ViroPharma Announces Appointment of Julie H. McHugh to Board of Directors
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at J.P. Morgan Healthcare Conference
9. Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit J-code
10. PAREXEL Announces Date of Second Quarter Fiscal Year 2012 Earnings Release and Conference Call
11. Cyberonics Announces FDA Approval of Re-Designed AspireHC™ Generator for VNS Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 Eli Lilly and ... the neoMONARCH study of abemaciclib, a cyclin-dependent kinase (CDK) ... of reducing expression of Ki67, a biomarker of cell ... the Phase 2 trial presented during the official press ... (SABCS) evaluated abemaciclib, both alone or in combination with ...
(Date:12/7/2016)... Global Cervical Dysplasia Market: Scope and ... dysplasia market analyzes the current and future prospects ... executive summary, including a market snapshot that provides ... The research is a combination of primary and ... our research efforts along with information collected from ...
(Date:12/7/2016)... REPORT OBJECTIVES The report ... intelligence on a market segment, based on geography. ... in the report. The primary objectives of this ... intelligence through detailed segmentation, 2) market size and ... developments, market situation, trends, 3) detailed analysis of ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... 2016 , ... Healthcare is in flux. The GOP wants ... mass media launching of story movements to highlight what's most unfair about healthcare. ... such a movement can generate the network power to improve healthcare policies in ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... that serve communities in and around the greater Phoenix metropolitan region, is announcing ... Connection. , The mission of the Homeless Youth Connection is to promote community ...
(Date:12/7/2016)... PA (PRWEB) , ... December 07, 2016 , ... ... with the announcement that it is one of the early adopters completing EU-U.S. Privacy ... Framework is designed to provide companies on both sides of the Atlantic with a ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... wrinkles and deep lines by smoothing and tightening the skin of the face ... there to address facial aging with very little downtime, Silhouette Instalift is a ...
(Date:12/7/2016)... ... December 07, 2016 , ... It is vital for any lab to secure ... data. The team at Beckman Coulter has designed Kaluza, templates with advanced analytical tools ... need to operate in a GLP (Good Laboratory Practice) fashion. , With features designed ...
Breaking Medicine News(10 mins):